-
Best Stocks: Hydrogenics Corporation (NASDAQ:HYGS), zulily (NASDAQ:ZU), CVD Equipment Corporation (NASDAQ:CVV), AbbVie Inc. (NYSE:ABBV), Five9 (NASDAQ:FIVN)
On Wednesday shares of Hydrogenics Corporation (NASDAQ:HYGS) closed at $10.96. Company’s sales growth for last 5 years was 19.30% and EPS growth for next 5 years is recorded as 25.00%. Hydrogenics Corporation (NASDAQ:HYGS) announced that it has entered into a binding agreement with a syndicate of lenders led by Cinnamon Investments Limited for an 18…
-
Stocks News Alert: CVD Equipment Corporation (NASDAQ:CVV), Apache Corp. (NYSE:APA), Chembio Diagnostics (NASDAQ:CEMI), EPR Properties (NYSE:EPR), MeetMe (NASDAQ:MEET)
On 12 February, CVD Equipment Corporation (NASDAQ:CVV) announced that it received in excess of $45 Million in orders during 2014. On Thursday shares of CVD Equipment Corporation (NASDAQ:CVV) closed at $14.94. Company’s sales growth for last 5 years was -0.20%. On 12 February, Apache Corp. (NYSE:APA) announced a fourth-quarter 2014 net loss of $4.8 billion…
-
Market Wrap Up: MGIC Investment Corp. (NYSE:MTG), CVD Equipment Corporation (NASDAQ:CVV), Sapiens International Corporation (NASDAQ:SPNS), Mettler-Toledo International (NYSE:MTD), Grana y Montero (NYSE:GRAM)
MGIC Investment Corp. (NYSE:MTG) will release its Q414 earnings data on Tuesday, January 20th. On Friday shares of MGIC Investment Corp. (NYSE:MTG) closed at $8.58. Company’s sales growth for last 5 years was -10.30% and EPS growth for next 5 years is recorded as 10.00%. CVD Equipment Corporation (NASDAQ:CVV), The Securities and Exchange Commission has…
-
Must Watch These 5 Stocks: CVD Equipment Corporation (NASDAQ:CVV), Sprint Corporation (NYSE:S), Keryx Biopharmaceuticals Inc. (NASDAQ:KERX), Cellcom Israel (NYSE:CEL), Envivio (NASDAQ:ENVI)
CVD Equipment (NYSE:CVV) CEO Leonard A. Rosenbaum sold 20,000 shares of the company’s stock on the open market in a transaction dated Monday, January 12th. The shares were sold at an average price of $15.45, for a total transaction of $309,000.00. Following the transaction, the chief executive officer now directly owns 797,870 shares of the…
-
Why These Are Hot: CVD Equipment Corporation (NASDAQ:CVV), Starbucks Corporation (NASDAQ:SBUX), HMS Holdings Corp. (NASDAQ:HMSY), State Auto Financial Corp. (NASDAQ:STFC), Vectren (NYSE:VVC)
CVD Equipment (NYSE:CVV) CEO Leonard A. Rosenbaum sold 20,000 shares of the company’s stock in a transaction dated Thursday, January 8th. The shares were sold at an average price of $15.07, for a total transaction of $301,400.00. Following the sale, the chief executive officer now directly owns 817,870 shares in the company, valued at approximately…
-
Stocks News Alert: Baidu (NASDAQ:BIDU), Concord Medical Services Holdings Limited (NYSE:CCM), Universal Display Corp. (NASDAQ:OLED), Sierra Wireless Inc. (NASDAQ:SWIR), CVD Equipment (NASDAQ:CVV)
China’s Internet giant Baidu Inc. (NASDAQ:BIDU) on 30 December declared that Baidu Antivirus, its security software has been awarded the ISO/IEC 27001 certification by the British Standards Institution (BSI Group) for its brilliant management of information security. On Friday shares of Baidu Inc (ADR) (NASDAQ:BIDU) closed at $226.90. Company’s sales growth for last 5 years…
-
Stocks to Keep Eyes On: Gilead Sciences (NASDAQ:GILD), ArcelorMittal SA (ADR) (NYSE:MT), BBVA Banco Frances (NYSE:BFR), IGI, Laboratories (NYSEMKT:IG), CVD Equipment (NASDAQ:CVV)
Gilead Sciences Inc. (NASDAQ:GILD) agreed to make its hepatitis C medicines the exclusive treatments for CVS Health Corp. (CVS) customers, intensifying a drug-industry rivalry to win patients for the $1,000-a-day medicines. Gilead Sciences Inc. (NASDAQ:GILD) in last trading activity moved up 1.98% to close at $96.79. Company weekly performance is 3.19% while its quarterly performance…
-
Investor’s pick: CVD Equipment Corporation (NASDAQ:CVV), Genworth Financial (NYSE:GNW), USG Corporation (NYSE:USG), Sprint Corporation (NYSE:S), Akebia Therapeutics (NASDAQ:AKBA)
CVD Equipment Corporation (NYSE:CVV) CEO Leonard A. Rosenbaum sold 9,691 shares of the stock on the open market in a transaction dated Monday, December 22nd. The stock was sold at an average price of $15.02, for a total value of $145,558.82. Following the transaction, the chief executive officer now directly owns 838,070 shares in the…
-
Stocks to Watch: Akebia Therapeutics (NASDAQ:AKBA), Spirit Realty Capital (NYSE:SRC), Murphy USA Inc. (NYSE:MUSA), Frisch’s Restaurants (NYSEMKT:FRS), CVD Equipment (NYSE:CVV)
Akebia Therapeutics, Inc. (NASDAQ:AKBA) Director Duane Nash sold 11,933 shares of the stock in a transaction that occurred on Friday, December 26th. The stock was sold at an average price of $11.23, for a total value of $134,007.59. Following the transaction, the director now directly owns 11,829 shares of the company’s stock, valued at approximately…